Geneos Wealth Management’s iShares 1-5 Year Investment Grade Corporate Bond ETF IGSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$900K Buy
17,123
+1,008
+6% +$53.3K 0.02% 534
2025
Q4
$852K Buy
16,115
+213
+1% +$11.3K 0.02% 541
2025
Q3
$843K Sell
15,902
-2,674
-14% -$141K 0.02% 529
2025
Q2
$980K Sell
18,576
-42,214
-69% -$2.21M 0.02% 537
2025
Q1
$3.18M Buy
60,790
+39,275
+183% +$2.04M 0.05% 382
2024
Q4
$1.11M Sell
21,515
-5,207
-19% -$271K 0.04% 395
2024
Q3
$1.41M Buy
26,722
+17,847
+201% +$929K 0.05% 339
2024
Q2
$455K Buy
8,875
+584
+7% +$29.8K 0.02% 513
2024
Q1
$425K Sell
8,291
-965
-10% -$49.4K 0.02% 523
2023
Q4
$475K Sell
9,256
-349
-4% -$17.5K 0.02% 494
2023
Q3
$479K Sell
9,605
-3,282
-25% -$164K 0.02% 478
2023
Q2
$647K Buy
12,887
+1,148
+10% +$57.8K 0.03% 411
2023
Q1
$593K Sell
11,739
-568
-5% -$28.5K 0.04% 408
2022
Q4
$613K Sell
12,307
-5,697
-32% -$282K 0.04% 378
2022
Q3
$887K Sell
18,004
-2,888
-14% -$146K 0.06% 274
2022
Q2
$1.06M Buy
20,892
+158
+0.8% +$8.04K 0.05% 307
2022
Q1
$1.07M Sell
20,734
-44,620
-68% -$2.35M 0.05% 334
2021
Q4
$3.52M Buy
65,354
+4,405
+7% +$238K 0.13% 167
2021
Q3
$3.33M Buy
60,949
+29,209
+92% +$1.6M 0.13% 178
2021
Q2
$1.74M Sell
31,740
-20,324
-39% -$1.11M 0.07% 261
2021
Q1
$2.85M Sell
52,064
-626
-1% -$34.4K 0.08% 245
2020
Q4
$1.94M Sell
52,690
-45,673
-46% -$2.51M 0.08% 240
2020
Q3
$5.39M Buy
98,363
+4,941
+5% +$271K 0.28% 82
2020
Q2
$5.11M Buy
93,422
+33,138
+55% +$1.79M 0.28% 80
2020
Q1
$3.13M Buy
60,284
+48,340
+405% +$2.57M 0.21% 110
2019
Q4
$640K Buy
11,944
+5,690
+91% +$305K 0.03% 391
2019
Q3
$335K Buy
6,254
+286
+5% +$15.3K 0.02% 502
2019
Q2
$318K Buy
5,968
+2,539
+74% +$134K 0.02% 526
2019
Q1
$181K Sell
3,429
-674
-16% -$35.2K 0.01% 676
2018
Q4
$211K Buy
4,103
+321
+8% +$16.6K 0.02% 585
2018
Q3
$196K Sell
3,782
-448
-11% -$23.2K 0.01% 651
2018
Q2
$219K Sell
4,230
-406
-9% -$21K 0.02% 548
2018
Q1
$240K Buy
4,636
+94
+2% +$4.89K 0.02% 488
2017
Q4
$237K Buy
4,542
+6
+0.1% +$315 0.02% 488
2017
Q3
$238K Sell
4,536
-996
-18% -$52.5K 0.02% 464
2017
Q2
$291K Buy
5,532
+144
+3% +$7.58K 0.03% 404
2017
Q1
$283K Sell
5,388
-10
-0.2% -$525 0.03% 395
2016
Q4
$283K Sell
5,398
-226
-4% -$11.9K 0.04% 374
2016
Q3
$297K Buy
5,624
+2,400
+74% +$127K 0.04% 361
2016
Q2
$170K Sell
3,224
-50
-2% -$2.64K 0.02% 478
2016
Q1
$172K Buy
+3,274
New +$172K 0.03% 467

Other funds holding IGSB

Geneos Wealth Management's IGSB Position: Q1 2026 in Review

Geneos Wealth Management increased its iShares 1-5 Year Investment Grade Corporate Bond ETF (IGSB) stake by 6.3% in Q1 2026, buying an estimated $53.3K and bringing the position to 17,123 shares worth $900K. The position accounts for 0.02% of the portfolio, ranked #534.

Geneos Wealth Management first reported a position in IGSB in Q1 2016 and has held it in 41 quarters since. The position peaked at $5.39M in Q3 2020. 1,009 funds tracked by Wall St. Rank hold IGSB as of Q1 2026.

  • Geneos Wealth Management held 17,123 shares of iShares 1-5 Year Investment Grade Corporate Bond ETF worth $900K as of Q1 2026.
  • Geneos Wealth Management bought 1,008 iShares 1-5 Year Investment Grade Corporate Bond ETF shares in Q1 2026, an estimated $53.3K.
  • iShares 1-5 Year Investment Grade Corporate Bond ETF made up 0.02% of Geneos Wealth Management's portfolio in Q1 2026, its #534 holding.
  • Geneos Wealth Management first reported a position in iShares 1-5 Year Investment Grade Corporate Bond ETF in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's iShares 1-5 Year Investment Grade Corporate Bond ETF position peaked at $5.39M in Q3 2020.
  • 1,009 funds tracked by Wall St. Rank held iShares 1-5 Year Investment Grade Corporate Bond ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.